Searching over 5,500,000 cases.

Buy This Entire Record For $7.95

Download the entire decision to receive the complete text, official citation,
docket number, dissents and concurrences, and footnotes for this case.

Learn more about what you receive with purchase of this case.

Garfield Beach CVS LLC v. Mollison Pharmacy

United States District Court, S.D. California

June 9, 2017

MOLLISON PHARMACY, SAMERA YOKOUB, an individual, and DOES 1 through 50, Defendants.


          Hon. Anthony J. Battaglia United States District Judge

         Pending before the Court is Plaintiff Garfield Beach CVS LLC's (“Plaintiff”) ex parte application for a temporary restraining order (“TRO”). (Doc. No. 3-1.) Defendants Mollison Pharmacy and Samera Yokoub opposed this application on May 10, 2017. (Doc. No. 15.) Pursuant to Judge Battaglia's Civil Case Procedures, no hearing was scheduled for this ex parte request. Having considered both parties' arguments, and for the reasons set forth below, the Court DENIES Plaintiff's request for an ex parte TRO.


         Plaintiff brings the following action for (1) violation of the Defend Trade Secrets Act (“DTSA”); (2) violation of the California Uniform Trade Secrets Act; (3) Breach of Contract; (4) Unfair Competition; (5) Conversion; and (6) Tortious Interference with Business Relationship/Contact. (Doc. No. 1 at 2.) Plaintiff is a subsidiary of CVS Health, the largest pharmacy health care provider in the United States. (Id. ¶ 2.) Defendant Mollison Pharmacy (“Mollison”) is a pharmacy business with its principal place of business in El Cajon, California. (Id. ¶ 5.) Defendant Samera Yokoub (“Yokoub”) is a California resident who was an employee of Express in El Cajon, which was bound to an agreement with Plaintiff to maintain its confidences. (Id. ¶ 6.)

         The events leading up to Plaintiff instituting this action are as follows. On April 11, 2017, Plaintiff closed a transaction and purchased the confidential inventory, trade secret prescription files, and goodwill of Double Star Pharmacy, Inc., doing business as El Cajon Express Pharmacy (“Express”). (Id. ¶ 3.) Due to the confidential and proprietary nature of the assets that were purchased from Express, Yokoub, and other key Express employees executed Key Employee Agreements (“KEA”) on or about March 28, 2017. (Id. ¶ 14.) The KEA detailed that the key Express employees would not (1) remove from Plaintiff's premises any confidential or proprietary business information; (2) not use for his/her own benefit, divulge, or disclose to anyone any of the information; and (3) that any breach of the KEA would result in irreparable harm to Plaintiff. (Id.)

         The prescription files that Plaintiff purchased included hard copy prescriptions, signature logs, customer lists, as well as similar electronic data that Express maintained in confidence. (Id. ¶ 16.) One of the subsets of the prescription files was known as a delivery log and it included customers' names, the prescription numbers, customers' signatures confirming receipt of the delivery, and co-pay information for each prescription. (Id. ¶ 20.) All of the prescription files are not readily available public information. (Id. ¶ 18.)

         Plaintiff contends that Yokoub was an Express driver that was entrusted with confidential and proprietary information including the delivery log. (Id. ¶ 21.) After Plaintiff purchased Express, Yokoub told Plaintiff that she had to quit as she had to care for her sick husband. (Id. ¶ 25.) Instead, Plaintiff alleges that Yokoub began working for Mollison, Plaintiff's competitor. (Id.) On that same day, Plaintiff demanded that Yokoub return the delivery logs from March through April; however, Plaintiff maintains that Yokoub failed to do so. (Id. ¶ 26.) Since Yokoub's separation with Plaintiff, Plaintiff has taken additional steps to secure and protect the delivery logs.[1] (Id. ¶ 29.)

         Further, Plaintiff contends that at the same time Yokoub began working for Mollison, Mollison began making an unprecedented number of prescription transfers from Plaintiff. (Id. ¶ 32.) Thus, Plaintiff alleges that Mollison and Yokoub (collectively referred to as “Defendants”) used Plaintiff's confidential and trade secret prescription file to contact Plaintiff's customers. (Id. ¶¶ 36-37.) Moreover, Plaintiff maintains that Defendants have made several misrepresentations regarding the state of their business in the hopes of directing patients to Mollison pharmacy. (Id. ¶ 35.) In sum, Plaintiff argues that Yokoub shared Plaintiff's confidential and proprietary trade secret information with Mollison so that they could actively work together in injuring Plaintiff's business and that they continue to retain the delivery logs. (Id. ¶ 37-39.)

         Plaintiff instituted this action on May 1, 2017. (Doc. No. 1.) The next day, Plaintiff filed its ex parte motion for a temporary restraining order (“TRO”), preservation of evidence, and order for expedited discovery. (Doc. No. 3.) On May 25, 2017, Magistrate Judge Dembin granted Plaintiff's motion for a preservation order and denied Plaintiff's motion for expedited discovery. (Doc. No. 21.)


         A temporary restraining order may be granted upon a showing “that immediate and irreparable injury, loss, or damage will result to the movant before the adverse party can be heard in opposition[.]” Fed.R.Civ.P. 65(b)(1)(A). The purpose of such an order, as a form of preliminary injunctive relief, is to preserve the status quo and prevent irreparable harm “just so long as is necessary to hold a hearing, and no longer.” Granny Goose Foods, Inc. v. Brotherhood of Teamsters & Auto Truck Drivers Local No. 70, 415 U.S. 423, 439 (1974). A request for a TRO is evaluated by the same factors that generally apply to a preliminary injunction. See Stuhlbarg Int'l Sales Co. v. John D. Brush & Co., 240 F.3d 832, 839 n.7 (9th Cir. 2001). However, a TRO is an “extraordinary remedy” and is “never awarded as of right.” Winter v. Natural Res. Def. Council, Inc., 555 U.S. 7, 24 (2008) (citing Munaf v. Geren, 553 U.S. 674, 689-90 (2008)). Instead, the moving party bears the burden of demonstrating four factors: (1) “he is likely to succeed on the merits”; (2) “he is likely to suffer irreparable harm in the absence of preliminary relief”; (3) “the balance of equities tips in his favor”; and (4) “an injunction is in the public interest.” Id. at 20 (citations omitted).

         Although a plaintiff must satisfy all four of the requirements set forth in Winter, the Ninth Circuit employs a sliding scale whereby “the elements of the preliminary injunction test are balanced, so that a stronger showing of one element may offset a weaker showing of another.” Alliance for the Wild Rockies v. Cottrell, 632 F.3d 1127, 1131 (9th Cir. 2011). Accordingly, if the moving party can demonstrate the requisite likelihood of irreparable harm and show that an injunction is in the public interest, a TRO may issue so long as there are serious questions going to the merits and the balance of hardships tips sharply in the moving party's favor. Id.


         Before reaching the merits of Plaintiff's TRO, the Court first turns to the evidentiary objections attached to Defendants' opposition to Plaintiff's ex parte application. (Doc. No. 15-1.) Defendants object to (1) the entire declaration of Joseph Shorez as unreliable as it is not dated and the signature is on a separate page; (2) paragraph 11 and 12 of Lauren Silva's declaration as lacking foundation and hearsay; and (3) the entire declaration by Stephen Vaudry as irrelevant, lacking foundation, and speculative. (Id.) After a thorough review of the law and the attached declarations, the Court SUSTAINS both Defendants' objection to Shorez's declaration as it is undated and their ...

Buy This Entire Record For $7.95

Download the entire decision to receive the complete text, official citation,
docket number, dissents and concurrences, and footnotes for this case.

Learn more about what you receive with purchase of this case.